Thoma Bravo, the US-based private equity firm, has invested in padoa, a French occupational health and safety (OHS) leader. The investment aims to bolster padoa’s strategic initiatives including AI integration, customer service enhancement, international expansion, particularly into the DACH region, and product innovation.
| Acquirer | Thoma Bravo (US) |
| Target | padoa (FR) |
| Type | Investment |
| Value | Undisclosed |
| Closing Date | June 24, 2026 |
| Advisors (Buy-Side) | Not disclosed |
| Advisors (Sell-Side) | Not disclosed |
| Legal Advisors (Buy-Side) | Not disclosed |
| Legal Advisors (Sell-Side) | Not disclosed |
The investment is part of Thoma Bravo's Europe Fund’s strategy to support high-growth European companies in the healthcare sector. The funding will enable padoa to further develop its artificial intelligence capabilities, enhance customer service offerings, and expand into new markets within Europe.
Strategic Rationale
Thoma Bravo sees significant potential for padoa's growth driven by increasing demand for advanced OHS solutions. The investment will empower the company to scale its operations through technological advancements and strategic market entry in underserved regions like Germany, Austria, and Switzerland.
Financial Context
Padoa has a solid track record of delivering innovative OHS services tailored to clients across various industries. With Thoma Bravo's backing, the company aims to accelerate its growth trajectory by leveraging financial resources for research & development, talent acquisition, and geographic expansion.
Outlook
The partnership between Thoma Bravo and padoa is expected to strengthen padoa’s position in the European OHS market while advancing key business areas such as AI integration and international presence. The funds will be allocated towards sustaining long-term growth through innovation and operational excellence.